It is nondialysable, and studies in patients with moderate chronic kidney disease (GFR <50 ml/min/1.73 m 2) demonstrated a reduced rate of fenofibrate excretion and accumulation of the drug with ...

Paradoxically, fenofibrate reversibly increases serum creatinine such that the drug's benefit on estimated glomerular filtration rate is only unmasked when the artificial creatinine elevation is ...

New Delhi, Jan 23 () Alembic Pharmaceuticals on Thursday said it has received final nod from the US health regulator for fenofibrate tablets, which reduces cholesterol and triglycerides in blood.